Pathophysiological evaluation of pilocytic astrocytoma in adults: Histopathological and immunohistochemical analysis
Pathology - Research and Practice · 2023
DOI: 10.1016/j.prp.2023.154593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2023. Verfasst von Samara F Santino und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo, Brazil; Laboratory of Molecular and Experimental …. Hauptthemen laut MEDLINE: Brain Neoplasms, Astrocytoma, Central Nervous System Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Pilocytic astrocytoma is a central nervous system tumor of slow growth, which represents 5 % of all gliomas and most often develops in the cerebellum (42-60 %), but can also arise in other neural areas, such as the optic pathway or hypothalamus (9-30 %); brainstem (9 %); spinal cord (2 %). In the pediatric population, this tumor is the second most common cause of neoplasms and, on the other hand, in adults, it is often rare, probably due to its aggressiveness in these individuals. Studies reveal that the origin of pilocytic astrocytoma is characterized by a fusion between the BRAF gene and the KIAA1549 locus, and the application of the immunohistochemistry technique for the analysis of BRAF protein expression can be a valuable tool for diagnostic purposes. Due to the relative rarity of this disease in adults, there are few publications on the most effective diagnostic and treatment strategies for this tumor. The general objective of this study was to analyze the histopathological and immunohistochemical characteristics of pilocytic astrocytoma in these patients. For this, a retrospective study of patients aged over 17 years with a diagnosis of pilocytic astrocytoma was carried out at the Department of Pathology of UNIFESP/EPM, from 1991 to 2015. In order to define BRAF positivity in the immunohistochemical analysis, at least three consecutive fields with more than 50 % immunostaining were used as criteria and, thus, it was inferred that the 7 cases analyzed were considered positive for the cytoplasmic marker BRAF V600E. Histopathological analysis associated with BRAF immunostaining is of paramount importance as a diagnostic method in these cases. However, future molecular studies will be necessary both for a better understanding of the aggressiveness and prognostic of this tumor and for research involving specific therapies for pilocytic astrocytoma in adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo, Brazil; Laboratory of Molecular and Experimental Pathology, Universidade Federal de São Paulo, Escola Paulista de Medic…
- Department of Pathology, Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo, Brazil.
Zitieren
APA
Santino, S. F., Salles, D., Stávale, J. N., & Malinverni, A. C. M. (2023). Pathophysiological evaluation of pilocytic astrocytoma in adults: Histopathological and immunohistochemical analysis. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2023.154593
Vancouver
Santino SF, Salles D, Stávale JN, Malinverni ACM. Pathophysiological evaluation of pilocytic astrocytoma in adults: Histopathological and immunohistochemical analysis. Pathology - Research and Practice. 2023. doi:10.1016/j.prp.2023.154593
BibTeX
@article{Santino2023,
author = {Santino, Samara F and Salles, Débora and Stávale, João N and Malinverni, Andréa C M},
title = {Pathophysiological evaluation of pilocytic astrocytoma in adults: Histopathological and immunohistochemical analysis},
journal = {Pathology - Research and Practice},
year = {2023},
doi = {10.1016/j.prp.2023.154593}
}
EUVIMED